Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease
about
Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New?Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease.Factors driving the aspirin exacerbated respiratory disease phenotype.The whole-genome expression analysis of peripheral blood mononuclear cells from aspirin sensitive asthmatics versus aspirin tolerant patients and healthy donors after in vitro aspirin challenge.Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease.Loki zupa (Luooukezupa) decoction reduced airway inflammation in an OVA-induced asthma mouse model.Aspirin-exacerbated respiratory disease: characteristics and management strategies.Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis.Mast cells in asthma--state of the art.Association of TRPM3 Polymorphism (rs10780946) and Aspirin-Exacerbated Respiratory Disease (AERD).Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets.Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory diseaseEffect of rapid desensitization on platelet inhibition and basophil activation in patients with aspirin hypersensitivity and coronary disease.
P2860
Q28079269-4AFA2EFD-2CA5-47B3-BAD3-4215BD9DF6E5Q30275780-896CF660-D193-4812-AC63-2974B007014EQ30276354-0A2038E0-1A12-435D-8388-76F21D8E18C5Q30300955-7ABD80AC-6D2B-4FEA-9B07-4BF0888235A9Q36357862-D8886704-FF29-43F9-8FFB-0E18176977ECQ36782772-126E1FB3-E694-4FA6-B1E4-6A2CEA28965AQ36853754-D0A968B6-BD47-4898-AD0D-3C5988B402B6Q38455960-63E2C219-E4C9-4FB9-B673-C2F90CD5EE65Q38609538-A11AE5C1-487A-4C6E-B47A-F623540B8EBAQ38633155-8FBD922E-9AD1-4797-995D-0ADB2A2FD87CQ40901391-77A843B4-A4BF-4588-BFD8-2380B6091298Q41050351-54853EEA-9929-42C6-8475-97B665CFC3BEQ42129014-AA61F3F3-2C4D-42F3-BA0C-2F370BAC4DF5Q47704546-CE29D553-A657-4EA4-8526-3B83CF8921CB
P2860
Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Aspirin activation of eosinoph ...... xacerbated respiratory disease
@ast
Aspirin activation of eosinoph ...... xacerbated respiratory disease
@en
type
label
Aspirin activation of eosinoph ...... xacerbated respiratory disease
@ast
Aspirin activation of eosinoph ...... xacerbated respiratory disease
@en
prefLabel
Aspirin activation of eosinoph ...... xacerbated respiratory disease
@ast
Aspirin activation of eosinoph ...... xacerbated respiratory disease
@en
P2860
P50
P921
P356
P1476
Aspirin activation of eosinoph ...... xacerbated respiratory disease
@en
P2093
Julie Negri
P2860
P356
10.4049/JIMMUNOL.1301753
P407
P577
2014-06-02T00:00:00Z